logo
Plus   Neg
Share
Email

Lowe's To Open 50 Cross Dock Delivery Terminals Over Next 18 Months - Quick Facts

Home improvement company Lowe's Companies, Inc. (LOW) announced Wednesday that it plans to open 50 cross dock delivery terminals, seven bulk distribution centers and four e-commerce fulfillment centers over the next 18 months.

This includes 20 cross dock terminals and one West Coast e-commerce fulfillment center in the second half of fiscal 2020. Together, the goal is to provide more same-day and next-day service offerings and enable faster e-commerce shipping across the country.

This move is part of its supply chain transformation to improve home delivery and support growing demand from DIY and Pro customers, including the opening of more than 13 different facilities across the U.S. in markets such as Chicago, Orlando, Riverside, California, and Columbus, Ohio.

In 2018, the company announced a $1.7 billion investment to expand its distribution network through 2023. The company and its third-party partners will create nearly 5,000 jobs to support this initial expansion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Despite the coronavirus pandemic, retailers are prepared for an early start to the holiday shopping season by offering discounts earlier so that consumers can buy and receive the gifts they want in time, the National Retail Federation or NRF said. The NRF also said it is launching a nationwide consumer education campaign called "New Holiday Traditions". Facebook (FB) has revealed new messaging features for Instagram, which will make it easier for users to stay in touch with others across Facebook's family of apps. The main change is that people using the Messenger app can now reach Instagram users, and vice versa. The users can control where they receive... Regeneron Pharmaceuticals, Inc. announced positive first data from a descriptive analysis of a seamless Phase 1/2/3 trial of its investigational antibody cocktail REGN-COV2 in COVID-19 patients. REGN-COV2 rapidly reduced viral load and associated symptoms in infected COVID-19 patients. The company said it plans rapidly to discuss results with regulatory authorities.
Follow RTT